Correlation between metal ions and clinical findings in subjects affected by Alzheimer's disease.
暂无分享,去创建一个
Beatrice Bocca | Giovanni Forte | Franco Giubilei | Cristina D'Ippolito | F. Giubilei | B. Bocca | G. Forte | A. Pino | F. Marchione | G. Bomboi | Valentina Bianchi | Anna Pino | Giuseppe Bomboi | Emanuela Medda | E. Medda | C. D’ippolito | Francesca Marchione | Micaela Sepe-Monti | Antonella De Carolis | V. Bianchi | A. de Carolis | M. Sepe-Monti | Francesca Marchione
[1] B Carragher,et al. Three-Dimensional Analysis of the Relationship Between Synaptic Pathology and Neuropil Threads in Alzheimer Disease , 1992, Journal of neuropathology and experimental neurology.
[2] J. D. Robertson,et al. Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.
[3] R. Tanzi,et al. Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.
[4] C. Masters,et al. Rapid induction of Alzheimer A beta amyloid formation by zinc. , 1994, Science.
[5] Xudong Huang,et al. Redox‐Active Metals, Oxidative Stress, and Alzheimer's Disease Pathology , 2004, Annals of the New York Academy of Sciences.
[6] S. Brenner. Elevation of serum copper levels in Alzheimer’s disease , 2003, Neurology.
[7] E Magni,et al. Mini‐Mental State Examination: a normative study in Italian elderly population , 1996, European journal of neurology.
[8] D. Selkoe,et al. The seminal role of beta-amyloid in the pathogenesis of Alzheimer disease. , 1992, Alzheimer disease and associated disorders.
[9] L. Mucke,et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.
[10] A. Bush. Copper, zinc, and the metallobiology of Alzheimer disease. , 2003, Alzheimer disease and associated disorders.
[11] G. Perry,et al. The role of metals in neurodegenerative diseases. , 2000, Cellular and molecular biology.
[12] A. Nunomura,et al. Oxidative Stress, Antioxidants, and Alzheimer Disease , 2000, Alzheimer disease and associated disorders.
[13] D. Selkoe. Cell biology of the beta-amyloid precursor protein and the genetics of Alzheimer's disease. , 1996, Cold Spring Harbor symposia on quantitative biology.
[14] Xudong Huang,et al. Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis* , 1998, The Journal of Biological Chemistry.
[15] B. Bocca,et al. Development of methods for the quantification of essential and toxic elements in human biomonitoring. , 2005, Annali dell'Istituto Superiore di Sanità.
[16] C. Höschl,et al. Alterations in calcium homeostasis as biological marker for mild Alzheimer's disease? , 2004, Physiological research.
[17] P. Stanzione,et al. Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson’s disease , 2004, Journal of Neural Transmission.
[18] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[19] C. Behl. Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease. , 1997, Cell and tissue research.
[20] R. Tanzi,et al. Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease. , 1999, Metal ions in biological systems.
[21] Ashley I. Bush,et al. The metallobiology of Alzheimer's disease , 2003, Trends in Neurosciences.
[22] D. Selkoe,et al. The Seminal Role of β‐Amyloid in the Pathogenesis of Alzheimer Disease , 1992 .
[23] C. Masters,et al. A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease. , 1993, The Journal of biological chemistry.
[24] Jae-Young Koh,et al. Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Salmon,et al. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.
[26] R. Tanzi,et al. Modulation of A beta adhesiveness and secretase site cleavage by zinc. , 1994, The Journal of biological chemistry.
[27] A. Korten,et al. The prevalence of dementia: A quantitative integration of the literature , 1987, Acta psychiatrica Scandinavica.
[28] A. Barnea,et al. Evidence for release of copper in the brain: Depolarization‐induced release of newly taken‐up 67copper , 1988, Synapse.
[29] Carsten Schmidt,et al. Evidence for a copper-binding superfamily of the amyloid precursor protein. , 2002, Biochemistry.
[30] B. Bocca,et al. High-throughput microwave-digestion procedures to monitor neurotoxic elements in body fluids by means of inductively coupled plasma mass spectrometry , 2003, Analytical and bioanalytical chemistry.
[31] Y. Christen,et al. Oxidative stress and Alzheimer disease. , 2000, The American journal of clinical nutrition.
[32] A. Bush,et al. Specific metal-catalysed protein oxidation reactions in chronic degenerative disorders of ageing: focus on Alzheimer's disease and age-related cataracts. , 2001, Novartis Foundation symposium.
[33] D. Harman,et al. Free radical theory of aging: Alzheimer’s disease pathogenesis , 1995, AGE.
[34] Xudong Huang,et al. Metal Chelation as a Potential Therapy for Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.
[35] C. Masters,et al. Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice , 1999, Brain Research.
[36] A. Pascale,et al. Calcium alterations in Alzheimer's disease: pathophysiology, models and therapeutic opportunities. , 1999, Pharmacological research.
[37] J. Connor,et al. Abnormal localization of iron regulatory protein in Alzheimer's disease , 1998, Brain Research.
[38] G. Perry,et al. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. , 2000, Antioxidants & redox signaling.
[39] M. Luca,et al. Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome. , 1996, Archives of neurology.